GlaxoSmithKline plc

(NYSE:GSK)

Latest On GlaxoSmithKline plc (GSK):

Date/Time Type Description Signal Details
2024-08-16 05:57 ESTDividendA dividend of $0.39 has been announced on Jul 31, 2024. It will be paid Oct 10, 2024 with an ex-dividend date of Aug 16, 2024.Neutral
2024-05-16 05:57 ESTDividendA dividend of $0.38 has been announced on May 1, 2024. It will be paid Jul 11, 2024 with an ex-dividend date of May 16, 2024.Neutral
2024-02-22 05:13 ESTDividendA dividend of $0.41 has been announced on Feb 1, 2024. It will be paid Apr 11, 2024 with an ex-dividend date of Feb 22, 2024.Neutral
2023-11-16 04:56 ESTDividendA dividend of $0.34 has been announced on Nov 1, 2023. It will be paid Jan 11, 2024 with an ex-dividend date of Nov 16, 2023.Neutral
2023-08-17 05:56 ESTDividendA dividend of $0.36 has been announced on Jul 26, 2023. It will be paid Oct 12, 2023 with an ex-dividend date of Aug 17, 2023.Neutral
2023-05-18 05:56 ESTDividendA dividend of $0.35 has been announced on Apr 26, 2023. It will be paid Jul 13, 2023 with an ex-dividend date of May 18, 2023.Neutral
2023-05-16 06:27 ESTNewsWhat To Expect From GSK In 2023N/A
2023-05-15 16:58 ESTNewsTeva appeal against GSK over Coreg generics denied by Supreme CourtN/A
2023-05-12 16:36 ESTNewsGSK says Canadian court dismisses potential Zantac class suitN/A
2023-05-12 16:36 ESTNewsGSK cuts its Haleon stake in $1B share saleN/A
2023-05-12 16:36 ESTNewsGSK lauds preliminary late-stage results for meningococcal vaccineN/A
2023-05-12 02:42 ESTNewsGSK to cut its Haleon stake in $1B share saleN/A
2023-05-03 17:23 ESTNewsHaleon Q1 profit rises, margins squeeze; Pfizer plans stake sale in coming monthsN/A
2023-05-03 17:23 ESTNewsGSK’s Arexvy becomes first U.S.-cleared shot for respiratory syncytial virusN/A
2023-04-28 12:58 ESTNewsPfizer's RSV shot could take years to reach low income countries — reportN/A
2023-04-27 12:03 ESTNewsGSK RSV vaccine for older adults inches towards EU approval after EMA nodN/A
2023-04-26 23:42 ESTNewsGSK plc (GSK) Q1 2023 Earnings Call TranscriptN/A
2023-04-26 11:33 ESTNewsGSK vaccine sales drive growth amid COVID products decline, affirms FY23 outlookN/A
2023-04-26 11:33 ESTNewsGSK Non-GAAP EPS of 37.0p, revenue of £6.95B; reaffirms FY23 guidanceN/A
2023-04-25 23:21 ESTNewsWith GlaxoSmithKline up 5% YTD, will its Q1 earnings also shine?N/A
2023-04-25 11:18 ESTNewsGSK's Jemperli gets review in EU for expanded use in uterus cancerN/A
2023-04-20 15:27 ESTNewsGSK consumer health spinoff Haleon eyes FY23 organic revenue growth at top end of outlookN/A
2023-04-18 16:59 ESTNewsBellus surges ~100% after GSK reaches deal to acquire cough drugmaker for ~$2BN/A
2023-04-18 16:58 ESTNewsHot Stocks: BLU rises on buy out offer from GSK; ERIC slips on earnings; NVDA, GMDA gains; MP slidesN/A
2023-04-17 14:26 ESTNewsGSK oral UTI antibiotic meets key goals in late-stage trialsN/A
2023-04-12 09:50 ESTNewsGSK Facing Legal Woes, No Longer A BuyN/A
2023-04-11 20:39 ESTNewsAdaptimmune to regain rights to cancer drug programs from GSKN/A
2023-04-10 14:26 ESTNewsGSK Vs. Bristol-Myers Squibb: Who's More Underrated By Mr. MarketN/A
2023-04-03 12:14 ESTNewsArrowhead stock pops after $30M milestone from GSK under liver drug pactN/A
2023-03-30 18:46 ESTNewsViatris, Aurobindo, Cipla to make generics of ViiV's HIV drug for low income countriesN/A
2023-03-30 18:45 ESTNewsSCYNEXIS jumps 92% on licensing deal with GSK for anti-fungal agentN/A
2023-03-28 14:10 ESTNewsGSK's Jemperli cuts risk of death in uterus cancer patients subset by 72% but lower overall in trialN/A
2023-03-24 18:39 ESTNewsGSK stock falls after California court ruling on Zantac; company disagrees with decisionN/A
2023-03-14 12:27 ESTNewsGSK's 5-in-1 meningococcal vaccine meets phase 3 goals, sets stage for new race with PfizerN/A
2023-03-14 12:27 ESTNewsGSK Nucala for severe asthma gets review in ChinaN/A
2023-03-10 00:48 ESTNewsPfizer, GSK gearing up for RSV vaccine rollouts this yearN/A
2023-03-07 11:57 ESTNewsFDA head Califf pressed by congresswoman on GlaxoSmithKline Zantac cancer risksN/A
2023-03-01 18:36 ESTNewsGSK wins FDA AdCom backing for RSV vaccineN/A
2023-02-23 04:56 ESTDividendA dividend of $0.34 has been announced on Feb 1, 2023. It will be paid Apr 13, 2023 with an ex-dividend date of Feb 23, 2023.Neutral
2023-02-22 19:29 ESTNewsGSK's long-acting HIV med Cabenuva equals Gilead's daily BiktarvyN/A
2023-02-16 20:29 ESTNewsPfizer, GSK to face FDA AdCom meetings for RSV vaccines from late FebruaryN/A
2023-02-15 17:45 ESTNewsGSK kept quiet about cancer risks of heartburn drug Zantac for 40 years – BloombergN/A
2023-02-14 02:28 ESTNewsGlaxoSmithKline ends work with Vir Biotechnology on next-generation COVID treatmentsN/A
2023-02-13 00:51 ESTNewsSuper Bowl ads boost sales of drugs, yet only handful of companies advertising this yearN/A
2023-02-11 22:15 ESTNewsSuper Bowl ads boost sales of drugs, yet only two companies advertising this yearN/A
2023-02-10 06:46 ESTNewsGSK Jemperli gets FDA full approval to treat certain uterus cancer patientsN/A
2023-02-04 03:40 ESTNewsWhy did Sanofi stock jump up today? Zantac litigation tossed out by judgeN/A
2023-02-03 14:38 ESTNewsGSK's Innovative Specialty Products Need More Insurance Coverage, Still A BuyN/A
2023-02-03 01:24 ESTNewsGSK: Solid Results, Ambitious Plans And Generous Dividend, But Pipeline Lacks A PunchN/A
2023-02-02 11:20 ESTNewsFDA approves GSK's anemia drug Jesduvroq for kidney disease patients on dialysisN/A

About GlaxoSmithKline plc (GSK):

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; Novartis; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; and CureVac. The company also has an agreement with Vir Biotechnology, Inc for research and development of new therapies for influenza and other respiratory viruses. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

GSK Quotes by TradingView

See Advanced Chart

General

  • Name GlaxoSmithKline plc
  • Symbol GSK
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 94,066
  • Last Split Factor2:1
  • Last Split Date1991-11-12
  • Fiscal Year EndDecember
  • IPO Date1986-07-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.gsk.com
View More

Valuation

  • Trailing PE 36.77
  • Forward PE 13.21
  • Price/Sales (Trailing 12 Mt.) 1.93
  • Price/Book (Most Recent Quarter) 4.51
  • Enterprise Value Revenue 3.5
  • Enterprise Value EBITDA 14.05
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $2.88
  • Next Year EPS Estimate $3.13
  • Profit Margin 17%
  • Return on Assets 7%
  • Return on Equity 33%
  • Earnings Per Share $0.99
  • Revenue Per Share $0
  • Gross Profit 23.21 billion
  • Quarterly Earnings Growth -1.8%
View More

Highlights

  • Market Capitalization 90.35 billion
  • PE Ratio 14.5
  • PEG Ratio 8.93
  • Analyst Target Price $46.57
  • Book Value Per Share $2.41
View More

Share Statistics

  • Shares Outstanding 2.52 billion
  • Shares Float 2.45 billion
  • % Held by Insiders 1%
  • % Held by Institutions 11.88%
  • Shares Short 20.5 million
  • Shares Short Prior Month 14.16 million
  • Short Ratio 2.68
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.35
  • 52 Week High $40.98
  • 52 Week Low $29.78
  • 50 Day Moving Average 35.46
  • 200 Day Moving Average 36.9
View More

Dividends

  • Forward Annual Dividend Rate $2.11
  • Forward Annual Dividend Yield 5.8%
  • Payout Ratio 70%
  • Dividend Date 2021-04-08
  • ExDividend Date 2021-02-18
  • Dividend Per Share $1.06
  • Dividend Yield 3.44%
View More

GlaxoSmithKline plc (GSK) Dividend Calendar:

GlaxoSmithKline plc pays an annual dividend of $2.11 per share, with a dividend yield of 3.44%.
GSK's last dividend payment was made to shareholders on April 8, 2021.
GlaxoSmithKline plc pays out 70% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

GlaxoSmithKline plc (GSK) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-03$N/A$0.64$0.4832.01%
2020-09-302020-10-28$N/A$0.92$0.867.87%
2020-06-302020-07-29$N/A$0.50$0.56-11.98%
2020-03-312020-04-29$9.09 billion$0.93$0.6249.18%
2019-12-312020-02-05$11.81 billion$0.64$0.606.57%
2019-09-302019-10-30$11.54 billion$0.99$0.8023.9%
2019-06-302019-07-24$9.92 billion$0.76$0.6221.9%
2019-03-312019-05-01$10.04 billion$0.78$0.6422.57%
2018-12-312019-02-06$10.46 billion$0.81$0.7015.19%
2018-09-302018-10-31$10.55 billion$0.91$0.865.92%
2018-06-302018-07-25$9.61 billion$0.74$0.78-4.77%
2018-03-312018-04-25$10.14 billion$0.69$0.69-0.58%
2017-12-312018-02-07$10.72 billion$0.76$0.6712.49%
2017-09-302017-10-25$11.26 billion$0.86$0.825.37%
2017-06-302017-07-26$9.98 billion$0.71$0.675.45%
2017-03-312017-04-26$9.36 billion$0.64$0.623.58%
2016-12-312017-02-08$8.11 billion$0.65$0.625.04%
2016-09-302016-10-26$9.66 billion$0.78$0.745.68%
2016-06-302016-07-27$8.04 billion$0.64$0.5516.63%
2016-03-312016-04-27$9.09 billion$0.58$0.5113.25%
2015-12-312016-02-03$8.74 billion$0.52$0.512.08%
2015-09-302015-10-28$8.7 billion$0.70$0.5820.69%
2015-06-302015-07-29$9.86 billion$0.09
2015-03-312015-05-06$8.46 billion$5.03
2014-12-312015-02-04$8.65 billion$0.67
2014-09-302014-10-22$8.32 billion$0.93$0.40132.5%
2014-06-302014-07-23$9.88 billion$0.45
2014-03-312014-04-30$9.48 billion$0.46
2013-12-312014-02-05$12.39 billion$0.97$0.961.04%
2013-09-302013-10-23$11.97 billion$0.61
2013-06-302013-07-24$10.2 billion$0.65
2013-03-312013-04-24$10 billion$0.62
2012-12-312013-02-06$11.45 billion$1.04$0.7244.44%
2012-09-302012-10-31$11.27 billion$0.71
2012-06-302012-07-25$10.04 billion$0.83$0.86-3.49%
2012-03-312012-04-25$10.73 billion$0.85$0.91-6.59%
2011-12-312012-02-07$10.66 billion$0.78$0.6618.18%
2011-09-302011-10-26$10.51 billion$0.90$0.93-3.23%
2011-06-302011-07-26$10.81 billion$0.71$0.77-7.79%
2011-03-312011-04-27$10.57 billion$0.95$0.99-4.04%
2010-12-312011-02-03$10.36 billion-$0.42
2010-09-302010-10-21$11.85 billion$0.78
2010-06-302010-07-21$10.32 billion-$0.18
2010-03-312010-04-28$11.17 billion$0.81
2009-12-312010-02-04$13.42 billion$1.04
2009-09-302009-10-28$10.21 billion$0.86
2009-06-302009-07-22$12.56 billion$0.89
2009-03-312009-04-22$9.68 billion$0.64
2008-12-312009-02-05$4.55 billion$0.59
2008-09-302008-10-22$8.04 billion$0.75
2008-06-302008-07-23$11.72 billion$0.97
2008-03-312008-04-23$11.29 billion$0.96
2007-12-312008-02-07$10.94 billion$1.00$0.8419.05%
2007-09-302007-10-24$11.53 billion$0.95$0.950%
2007-06-302007-07-25$11.6 billion$0.94$0.940%
2007-03-312007-04-25$11.01 billion$1.06$1.050.95%
2006-12-312007-02-08$13.17 billion$0.80$0.84-4.76%
2006-09-302006-10-26$10.82 billion$0.92
2006-06-302006-07-26$11.38 billion$0.85
2006-03-312006-04-27$10.11 billion$0.92
2005-12-312006-02-08$9.39 billion$0.69$0.656.15%
2005-09-302005-10-27$9.76 billion$0.76$0.77-1.3%
2005-06-302005-07-28$8.92 billion$0.75
2005-03-312005-04-28$9.79 billion$0.80$0.83-3.61%
2004-12-312005-02-10$11.83 billion$0.65$0.67-2.99%
2004-09-302004-10-28$9.04 billion$0.79$0.729.72%
2004-06-302004-07-27$9.04 billion$0.73$0.75-2.67%
2004-03-312004-04-29$9.1 billion$0.71$0.692.9%
2003-12-312004-02-06$11.52 billion$0.54$0.65-16.92%
2003-09-302003-10-22$9.22 billion$0.66$0.618.2%
2003-06-302003-07-23$9.27 billion$0.78$0.6913.04%
2003-03-312003-04-30$8.25 billion$0.69$0.5916.95%
2002-12-312003-02-12$11.14 billion$0.65$0.650%
2002-09-302002-10-23$7.74 billion$0.51$0.510%
2002-06-302002-07-25$7.95 billion$0.65$0.650%
2002-03-312002-04-25$7.31 billion$0.54$0.531.89%
2001-12-312002-02-14$8.38 billion$0.59$0.581.72%
2001-09-302001-10-23$7.24 billion$0.46$0.452.22%
2001-06-302001-07-24$7.33 billion$0.57$0.570%
2001-03-312001-05-18$6.9 billion$0.47$0.454.44%
2000-06-302000-07-01$3.83 billion$0.52$0.89-41.57%
2000-03-312000-06-30$3.38 billion$0.52$0.89-41.57%
1999-12-312000-02-16$0.89$0.92-3.26%
1998-12-311999-02-18$0.93$0.859.41%
1998-06-301998-08-12$0.77$0.79-2.53%
1997-06-301997-08-04$0.96$0.951.05%
1996-12-311997-03-07$0.85$0.90-5.56%
1996-06-301996-08-05$0.89$0.845.95%
1995-12-311996-02-22$0.70$0.75-6.67%
1994-12-311995-02-07$0.79$0.729.72%
1994-06-301994-09-08$0.70$0.700%
1993-06-301993-08-19$0.59$0.68-13.24%

GlaxoSmithKline plc (GSK) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

GlaxoSmithKline plc (GSK) Chart:

GlaxoSmithKline plc (GSK) News:

Below you will find a list of latest news for GlaxoSmithKline plc (GSK) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

GlaxoSmithKline plc (GSK) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-11-20350CALL0 145.1TRUE00
2026-11-204011.71CALL3 1734.05TRUE11.710
2026-11-20457.3CALL18 38830.84TRUE0.130.02
2026-11-20503.9CALL5 40528.48TRUE00
2026-11-20551.65CALL75 90127.47FALSE-0.1-0.06
2026-11-20600.66CALL67 156927.82FALSE-0.04-0.06
2026-11-20650.3CALL5 17029.58FALSE0.30
2026-11-20700CALL0 12732.59FALSE00
2026-11-20750CALL0 8536.07FALSE00
2026-11-20800CALL0 1737.94FALSE00
2026-11-20350PUT0 16042.05FALSE00
2026-11-20400.37PUT1 4935.42FALSE0.370
2026-11-20450.95PUT52 57831FALSE-0.02-0.02
2026-11-20502.55PUT142 76929.69FALSE0.030.01
2026-11-20555.34PUT0 12629.34TRUE00
2026-11-20600PUT0 231.13TRUE00
2026-11-20650PUT0 135.31TRUE00
2026-11-20700PUT0 042.27TRUE00
2026-11-20750PUT0 048.22TRUE00
2026-11-20800PUT0 053.33TRUE00
2027-01-15200CALL0 1279.71TRUE00
2027-01-15230CALL0 268.12TRUE00
2027-01-15250CALL0 161.24TRUE00
2027-01-15280CALL0 351.92TRUE00
2027-01-15300CALL0 3746.26TRUE00
2027-01-153318.7CALL4 7638.44TRUE18.70
2027-01-153516.6CALL6 31337.38TRUE16.60
2027-01-153813.75CALL35 27132.73TRUE13.750
2027-01-154011.95CALL53 54132.66TRUE-0.15-0.01
2027-01-154210.6CALL1 38230.52TRUE0.20.02
2027-01-15457.9CALL6 125630.29TRUE00
2027-01-15470CALL0 72128.46TRUE00
2027-01-15504.5CALL82 94927.66TRUE-0.1-0.02
2027-01-15552.35CALL37 84326.89FALSE-0.05-0.02
2027-01-15601.1CALL57 161726.98FALSE00
2027-01-15650.55CALL20 70627.26FALSE0.550
2027-01-15700.3CALL100 23728.33FALSE0.30
2027-01-15750CALL0 8630.96FALSE00
2027-01-15800CALL0 1332.06FALSE00
2027-01-15850CALL0 1035.63FALSE00
2027-01-15900CALL0 2437.4FALSE00
2027-01-15200PUT0 13286.43FALSE00
2027-01-15230PUT0 4174.92FALSE00
2027-01-15250PUT0 19251.28FALSE00
2027-01-15280PUT0 40359.61FALSE00
2027-01-15300PUT0 40942.87FALSE00
2027-01-15330.2PUT1 12138.51FALSE0.20
2027-01-15350PUT0 15937.49FALSE00
2027-01-15380.4PUT50 38234.32FALSE0.40
2027-01-15400PUT0 141732.43FALSE00
2027-01-15420.85PUT1 91731.27FALSE-0.05-0.06
2027-01-15450PUT0 51027.9FALSE00
2027-01-15471.95PUT0 38229.01FALSE00
2027-01-15502.95PUT8 31028.05FALSE-0.15-0.05
2027-01-15555.8PUT29 25427.55TRUE00
2027-01-15600PUT0 3128.24TRUE00
2027-01-15650PUT0 630.12TRUE00
2027-01-15700PUT0 333.61TRUE00
2027-01-15750PUT0 240.38TRUE00
2027-01-15800PUT0 044.8TRUE00
2027-01-15850PUT0 049.77TRUE00
2027-01-15900PUT0 054.37TRUE00
2027-02-19300CALL0 144.6TRUE00
2027-02-19350CALL0 1936.66TRUE00
2027-02-19400CALL0 2132.44TRUE00
2027-02-19458.3CALL1 4930.05TRUE8.30
2027-02-19500CALL0 16528.11TRUE00
2027-02-19552.75CALL5 7130.16FALSE-0.05-0.02
2027-02-19600CALL0 9527.19FALSE00
2027-02-19650.73CALL18 4227.46FALSE0.730
2027-02-19700CALL0 028.86FALSE00
2027-02-19750CALL0 630.55FALSE00
2027-02-19300PUT0 440.24FALSE00
2027-02-19350PUT0 5536.62FALSE00
2027-02-19400PUT0 15131.02FALSE00
2027-02-19451.75PUT31 9429.11FALSE1.750
2027-02-19503.59PUT0 128728.96FALSE00
2027-02-19556.3PUT0 34528.43TRUE00
2027-02-19600PUT0 1028.65TRUE00
2027-02-19650PUT0 029.76TRUE00
2027-02-19700PUT0 032.92TRUE00
2027-02-19750PUT0 038.48TRUE00
2028-01-21230CALL0 3443.49TRUE00
2028-01-21250CALL0 7238.86TRUE00
2028-01-21280CALL0 1236.17TRUE00
2028-01-21300CALL0 8234.64TRUE00
2028-01-21330CALL0 4533.57TRUE00
2028-01-213517.55CALL12 23032.04TRUE17.550
2028-01-21380CALL0 9031.59TRUE00
2028-01-21400CALL0 8730.87TRUE00
2028-01-214212.2CALL12 24429.75TRUE12.20
2028-01-214510.31CALL3 15029.5TRUE10.310
2028-01-21470CALL0 27929.19TRUE00
2028-01-21500CALL0 114428.56TRUE00
2028-01-21550CALL0 76527.94FALSE00
2028-01-21603.8CALL0 26827.38FALSE00
2028-01-21650CALL0 161827.1FALSE00
2028-01-21700CALL0 17127.22FALSE00
2028-01-21751.25CALL7 67827.01FALSE-0.05-0.04
2028-01-21800.95CALL5 2927.16FALSE00
2028-01-21850.7CALL5 12527.66FALSE00
2028-01-21900CALL0 7929.4FALSE00
2028-01-21230PUT0 641.38FALSE00
2028-01-21250PUT0 739.73FALSE00
2028-01-21280.55PUT1 2736.06FALSE0.550
2028-01-21300PUT0 7731.91FALSE00
2028-01-21330PUT0 3333.84FALSE00
2028-01-21351.35PUT1 12632.89FALSE1.350
2028-01-21380PUT0 3831.66FALSE00
2028-01-21402.2PUT0 30330.87FALSE00
2028-01-21420PUT0 2930.16FALSE00
2028-01-21450PUT0 11330.67FALSE00
2028-01-21470PUT0 2628.57FALSE00
2028-01-21500PUT0 46130.23FALSE00
2028-01-21550PUT0 7127.41TRUE00
2028-01-21600PUT0 19126.85TRUE00
2028-01-21650PUT0 3526.94TRUE00
2028-01-21700PUT0 5719.23TRUE00
2028-01-21750PUT0 521.71TRUE00
2028-01-21800PUT0 230.66TRUE00
2028-01-21850PUT0 033.51TRUE00
2028-01-21900PUT0 036.08TRUE00

Latest GSK Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST26$42.49
Jun 13, 2022 7:59 PM EST100$42.5
Jun 13, 2022 7:59 PM EST100$42.5
Jun 13, 2022 7:59 PM EST100$42.5
Jun 13, 2022 7:59 PM EST82$42.5

GlaxoSmithKline plc (GSK) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007207/0001654954-20-007207-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1131399/000083423720005483/0000834237-20-005483-index.htm
2020-10-07CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1131399/000087666120000890/0000876661-20-000890-index.htm
2020-10-1325-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1131399/000087666120000908/0000876661-20-000908-index.htm
2020-05-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000114036120011353/0001140361-20-011353-index.htm
2020-05-29SDhttps://www.sec.gov/Archives/edgar/data/1131399/000114036120012714/0001140361-20-012714-index.htm
2020-06-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000114036120014055/0001140361-20-014055-index.htm
2020-06-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000114036120014064/0001140361-20-014064-index.htm
2020-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000114036120014155/0001140361-20-014155-index.htm
2020-03-0620-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1131399/000119312520065064/0001193125-20-065064-index.htm
2020-03-06IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1131399/000119312520065087/0001193125-20-065087-index.htm
2020-09-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000119312520255620/0001193125-20-255620-index.htm
2020-09-28424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/1131399/000119312520255663/0001193125-20-255663-index.htm
2020-09-28FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1131399/000119312520256576/0001193125-20-256576-index.htm
2020-09-28FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1131399/000119312520256583/0001193125-20-256583-index.htm
2020-09-30424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/1131399/000119312520258975/0001193125-20-258975-index.htm
2020-10-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000119312520261165/0001193125-20-261165-index.htm
2020-10-018-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1131399/000119312520261169/0001193125-20-261169-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713119006905/0001387131-19-006905-index.htm
2019-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713119007820/0001387131-19-007820-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713119007880/0001387131-19-007880-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713119008140/0001387131-19-008140-index.htm
2019-12-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1131399/000138713119009776/0001387131-19-009776-index.htm
2020-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120000048/0001387131-20-000048-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001780/0001387131-20-001780-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001784/0001387131-20-001784-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001829/0001387131-20-001829-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001830/0001387131-20-001830-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001831/0001387131-20-001831-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001832/0001387131-20-001832-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001833/0001387131-20-001833-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001835/0001387131-20-001835-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001836/0001387131-20-001836-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001837/0001387131-20-001837-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001846/0001387131-20-001846-index.htm
2020-02-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001888/0001387131-20-001888-index.htm
2020-02-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120001890/0001387131-20-001890-index.htm
2020-02-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120002259/0001387131-20-002259-index.htm
2020-02-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120002354/0001387131-20-002354-index.htm
2020-05-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120004398/0001387131-20-004398-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120005115/0001387131-20-005115-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120005182/0001387131-20-005182-index.htm
2020-05-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120005188/0001387131-20-005188-index.htm
2020-06-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120005474/0001387131-20-005474-index.htm
2020-06-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120005869/0001387131-20-005869-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120005871/0001387131-20-005871-index.htm
2020-06-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120006012/0001387131-20-006012-index.htm
2020-07-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120006276/0001387131-20-006276-index.htm
2020-07-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120006322/0001387131-20-006322-index.htm
2020-07-143/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120006398/0001387131-20-006398-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120006467/0001387131-20-006467-index.htm
2020-07-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120006471/0001387131-20-006471-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120006601/0001387131-20-006601-index.htm
2020-07-22SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120006608/0001387131-20-006608-index.htm
2020-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120006914/0001387131-20-006914-index.htm
2020-08-03SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120006953/0001387131-20-006953-index.htm
2020-08-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120007821/0001387131-20-007821-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1131399/000138713120008376/0001387131-20-008376-index.htm
2020-10-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120008670/0001387131-20-008670-index.htm
2020-11-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1131399/000138713120009681/0001387131-20-009681-index.htm
2019-08-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419009830/0001654954-19-009830-index.htm
2019-08-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419009882/0001654954-19-009882-index.htm
2019-08-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419009931/0001654954-19-009931-index.htm
2019-09-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419010244/0001654954-19-010244-index.htm
2019-09-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419010310/0001654954-19-010310-index.htm
2019-09-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419010312/0001654954-19-010312-index.htm
2019-09-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419010330/0001654954-19-010330-index.htm
2019-09-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419010568/0001654954-19-010568-index.htm
2019-09-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419010816/0001654954-19-010816-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011127/0001654954-19-011127-index.htm
2019-09-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011196/0001654954-19-011196-index.htm
2019-09-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011212/0001654954-19-011212-index.htm
2019-10-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011300/0001654954-19-011300-index.htm
2019-10-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011314/0001654954-19-011314-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011593/0001654954-19-011593-index.htm
2019-10-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011661/0001654954-19-011661-index.htm
2019-10-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011663/0001654954-19-011663-index.htm
2019-10-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011742/0001654954-19-011742-index.htm
2019-10-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011745/0001654954-19-011745-index.htm
2019-10-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011751/0001654954-19-011751-index.htm
2019-10-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011753/0001654954-19-011753-index.htm
2019-10-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419011878/0001654954-19-011878-index.htm
2019-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419012095/0001654954-19-012095-index.htm
2019-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419012098/0001654954-19-012098-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419012156/0001654954-19-012156-index.htm
2019-11-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419012235/0001654954-19-012235-index.htm
2019-11-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419012255/0001654954-19-012255-index.htm
2019-11-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419012320/0001654954-19-012320-index.htm
2019-11-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419012403/0001654954-19-012403-index.htm
2019-11-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419012546/0001654954-19-012546-index.htm
2019-11-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419012655/0001654954-19-012655-index.htm
2019-11-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419013389/0001654954-19-013389-index.htm
2019-12-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419013520/0001654954-19-013520-index.htm
2019-12-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419013521/0001654954-19-013521-index.htm
2019-12-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419013587/0001654954-19-013587-index.htm
2019-12-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419013607/0001654954-19-013607-index.htm
2019-12-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419013802/0001654954-19-013802-index.htm
2019-12-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419013893/0001654954-19-013893-index.htm
2019-12-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419013989/0001654954-19-013989-index.htm
2019-12-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419014045/0001654954-19-014045-index.htm
2019-12-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419014048/0001654954-19-014048-index.htm
2019-12-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495419014175/0001654954-19-014175-index.htm
2020-01-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420000015/0001654954-20-000015-index.htm
2020-01-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420000211/0001654954-20-000211-index.htm
2020-01-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420000213/0001654954-20-000213-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420000346/0001654954-20-000346-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420000348/0001654954-20-000348-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420000354/0001654954-20-000354-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420000361/0001654954-20-000361-index.htm
2020-01-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420000408/0001654954-20-000408-index.htm
2020-01-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420000410/0001654954-20-000410-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420000450/0001654954-20-000450-index.htm
2020-02-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001018/0001654954-20-001018-index.htm
2020-02-036-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001060/0001654954-20-001060-index.htm
2020-02-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001122/0001654954-20-001122-index.htm
2020-02-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001129/0001654954-20-001129-index.htm
2020-02-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001172/0001654954-20-001172-index.htm
2020-02-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001301/0001654954-20-001301-index.htm
2020-02-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001320/0001654954-20-001320-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001388/0001654954-20-001388-index.htm
2020-02-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001716/0001654954-20-001716-index.htm
2020-02-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001717/0001654954-20-001717-index.htm
2020-02-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001720/0001654954-20-001720-index.htm
2020-02-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001721/0001654954-20-001721-index.htm
2020-02-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001727/0001654954-20-001727-index.htm
2020-02-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001755/0001654954-20-001755-index.htm
2020-02-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001756/0001654954-20-001756-index.htm
2020-02-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001759/0001654954-20-001759-index.htm
2020-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420001810/0001654954-20-001810-index.htm
2020-03-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420002105/0001654954-20-002105-index.htm
2020-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420002225/0001654954-20-002225-index.htm
2020-03-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420002350/0001654954-20-002350-index.htm
2020-03-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420002359/0001654954-20-002359-index.htm
2020-03-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420002492/0001654954-20-002492-index.htm
2020-03-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420002602/0001654954-20-002602-index.htm
2020-03-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420002812/0001654954-20-002812-index.htm
2020-03-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420002914/0001654954-20-002914-index.htm
2020-03-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420003032/0001654954-20-003032-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420003468/0001654954-20-003468-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420003645/0001654954-20-003645-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420003655/0001654954-20-003655-index.htm
2020-04-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420003807/0001654954-20-003807-index.htm
2020-04-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420003892/0001654954-20-003892-index.htm
2020-04-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004020/0001654954-20-004020-index.htm
2020-04-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004035/0001654954-20-004035-index.htm
2020-04-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004037/0001654954-20-004037-index.htm
2020-04-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004043/0001654954-20-004043-index.htm
2020-04-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004136/0001654954-20-004136-index.htm
2020-04-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004139/0001654954-20-004139-index.htm
2020-04-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004148/0001654954-20-004148-index.htm
2020-04-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004581/0001654954-20-004581-index.htm
2020-04-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004610/0001654954-20-004610-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004675/0001654954-20-004675-index.htm
2020-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004813/0001654954-20-004813-index.htm
2020-05-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004854/0001654954-20-004854-index.htm
2020-05-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004856/0001654954-20-004856-index.htm
2020-05-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004860/0001654954-20-004860-index.htm
2020-05-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420004972/0001654954-20-004972-index.htm
2020-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420005020/0001654954-20-005020-index.htm
2020-05-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420005145/0001654954-20-005145-index.htm
2020-05-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420005338/0001654954-20-005338-index.htm
2020-05-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420005693/0001654954-20-005693-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420005746/0001654954-20-005746-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420005949/0001654954-20-005949-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420006182/0001654954-20-006182-index.htm
2020-06-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420006413/0001654954-20-006413-index.htm
2020-06-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420006503/0001654954-20-006503-index.htm
2020-06-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420006671/0001654954-20-006671-index.htm
2020-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420006757/0001654954-20-006757-index.htm
2020-06-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420006823/0001654954-20-006823-index.htm
2020-06-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007034/0001654954-20-007034-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007207/0001654954-20-007207-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007536/0001654954-20-007536-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007538/0001654954-20-007538-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007545/0001654954-20-007545-index.htm
2020-07-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007620/0001654954-20-007620-index.htm
2020-07-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007664/0001654954-20-007664-index.htm
2020-07-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007696/0001654954-20-007696-index.htm
2020-07-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007697/0001654954-20-007697-index.htm
2020-07-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007807/0001654954-20-007807-index.htm
2020-07-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420007982/0001654954-20-007982-index.htm
2020-07-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420008059/0001654954-20-008059-index.htm
2020-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420008093/0001654954-20-008093-index.htm
2020-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420008101/0001654954-20-008101-index.htm
2020-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420008105/0001654954-20-008105-index.htm
2020-07-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420008244/0001654954-20-008244-index.htm
2020-08-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420008289/0001654954-20-008289-index.htm
2020-08-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420008303/0001654954-20-008303-index.htm
2020-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420008547/0001654954-20-008547-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420008980/0001654954-20-008980-index.htm
2020-09-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420009704/0001654954-20-009704-index.htm
2020-09-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420009781/0001654954-20-009781-index.htm
2020-09-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420009917/0001654954-20-009917-index.htm
2020-09-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420009923/0001654954-20-009923-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420009958/0001654954-20-009958-index.htm
2020-09-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420010015/0001654954-20-010015-index.htm
2020-09-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420010326/0001654954-20-010326-index.htm
2020-10-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420010712/0001654954-20-010712-index.htm
2020-10-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011026/0001654954-20-011026-index.htm
2020-10-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011029/0001654954-20-011029-index.htm
2020-10-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011034/0001654954-20-011034-index.htm
2020-10-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011035/0001654954-20-011035-index.htm
2020-10-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011037/0001654954-20-011037-index.htm
2020-10-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011120/0001654954-20-011120-index.htm
2020-10-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011123/0001654954-20-011123-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011210/0001654954-20-011210-index.htm
2020-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011347/0001654954-20-011347-index.htm
2020-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011507/0001654954-20-011507-index.htm
2020-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011516/0001654954-20-011516-index.htm
2020-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011526/0001654954-20-011526-index.htm
2020-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011625/0001654954-20-011625-index.htm
2020-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011650/0001654954-20-011650-index.htm
2020-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011704/0001654954-20-011704-index.htm
2020-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011718/0001654954-20-011718-index.htm
2020-11-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011764/0001654954-20-011764-index.htm
2020-11-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011784/0001654954-20-011784-index.htm
2020-11-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011811/0001654954-20-011811-index.htm
2020-11-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1131399/000165495420011814/0001654954-20-011814-index.htm

GlaxoSmithKline plc (GSK) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of GlaxoSmithKline plc (GSK). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1%
Institutional Ownership: 1188%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-10PLC GLAXOSMITHKLINEDirectorBuy177,777.0045.007,999,965.002,170,327.00https://www.sec.gov/Archives/edgar/data/1131399/000138713119006905/0001387131-19-006905-index.htm
2020-07-21PLC GLAXOSMITHKLINEDirectorBuy361,111.0018.006,499,998.002,248,304.00https://www.sec.gov/Archives/edgar/data/1131399/000138713120006601/0001387131-20-006601-index.htm
2020-05-21PLC GLAXOSMITHKLINEDirectorBuy83,333.0060.004,999,980.002,253,660.00https://www.sec.gov/Archives/edgar/data/1131399/000138713120005182/0001387131-20-005182-index.htm
2019-10-18PLC GLAXOSMITHKLINEInsiderBuy357,142.0028.009,999,976.002,982,855.00https://www.sec.gov/Archives/edgar/data/1131399/000138713119007820/0001387131-19-007820-index.htm
2020-07-14PLC GLAXOSMITHKLINEDirectorBuy833,333.0018.0014,999,994.003,150,732.00https://www.sec.gov/Archives/edgar/data/1131399/000138713120006467/0001387131-20-006467-index.htm
2020-07-24PLC GLAXOSMITHKLINE10% Share HolderBuy1,260,504.002.252,836,134.004,626,389.00https://www.sec.gov/Archives/edgar/data/1131399/000138713120006914/0001387131-20-006914-index.htm
2020-05-20PLC GLAXOSMITHKLINE10% Share HolderSell4,000,000.0025.75103,000,000.006,238,244.00https://www.sec.gov/Archives/edgar/data/1131399/000138713120005115/0001387131-20-005115-index.htm